The National Health Research Ethics Committee, Nigeria, has approved the use of an experimental Ebola drug, Zmapp, for treatment of patients infected with the virus. The committee, which composed research scientists, is a national body under the Federal Ministry of Health.
The endorsement is contained in a statement issued to newsmen by Prof. Clement Adebamowo,Chairman of the committee on Wednesday in Abuja. Continue...
The decision by the committee is coming on the heels of Tuesday’s approval by the World Health Organisation (WHO) on the use of Zmapp for treatment of Ebola patients.
